i-STAT CORPORATIONI Stat Corporation /De/ • December 29th, 2003 • Electromedical & electrotherapeutic apparatus
We are pleased to inform you that on December 12, 2003, i-STAT Corporation ("i-STAT") entered into an Agreement and Plan of Merger (the "Merger Agreement") with Abbott Laboratories ("Abbott") and Senator Acquisition Corporation (the "Purchaser"), a wholly owned subsidiary of Abbott. As provided in the Merger Agreement, the Purchaser today commenced a tender offer (the "Offer") to purchase, in cash, without interest, (i) all outstanding shares of i-STAT's common stock not already held by Abbott, including the associated rights to purchase preferred stock issued under i-STAT's stockholder protection agreement of June 26, 1995 (together, the "Common Shares"), for $15.35 per share (the "Offer Price"), (ii) all outstanding shares of i-STAT Series D convertible preferred stock, par value $.10 per share (the "Series D Shares" and, together with the Common Shares, the "Shares") at an amount per share equal to the Offer Price multiplied by the number of Common Shares into which such Series D Sh
